DongKook Pharmaceutical Co., Ltd.

ACTIVE

13 Heungdeok 1-ro, Giheung-gu, Yongin, Gyeonggi, South Koreawww.dkpharm.co.krPublic1,129 employeesEstablished: 1992-01-01

Also known as:

dongguk pharmaceutical jeje technology research institute co., ltd.

Clinical Trials

1 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1992

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

40.0%

Not Applicable

30.0%

Phase 3

20.0%

Phase 4

10.0%

Trial Status Distribution

Active, not recruiting

10.0%

Completed

80.0%

Unknown

10.0%

Clinical Trials

Trials sponsored by this organization (10)

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Phase 3

Completed

interventional

May 2024161 participants

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Phase 3

Completed

interventional

Jul 2021667 participants

Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds

Not Applicable

Completed

interventional

Mar 202182 participants

Page 1 of 2

Approvals

Approvals by Agency

PHILIPPINES

Philippines FDA

Approvals

Recent Approvals

News

No news articles found

Back to Organizations

DongKook Pharmaceutical Co., Ltd.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (10)

Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer

Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia

Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds

Efficacy and Safety of DKM420 in Patients With Osteoarthritis of Knee

Efficacy and Safety of DKB-119 in Patients in Crow's Feet

Pharmacokinetics and Safety of AmBisome and DKF-5122

Efficacy and Safety of DKF-306 in Patients With Periodontal Diseases

Safety, Tolerability and Pharmacokinetics of DKF-310 ( (Donepezil).

Approvals

Approvals by Agency

Recent Approvals

News